Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1231132.RAZujBtTxWjlNUpldKMK4lHBUNttkUs_faaFIhCzpd4B8130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231132.RAZujBtTxWjlNUpldKMK4lHBUNttkUs_faaFIhCzpd4B8130_provenance.
• NP1231133.RAmTArvekihvH8OMYLPCzKYLfcANchkRCDafxd5bLHuoQ130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231133.RAmTArvekihvH8OMYLPCzKYLfcANchkRCDafxd5bLHuoQ130_provenance.
• NP1231136.RAjXSuPbySNeZWo3zbJv5JjVfJXrx8rbUOBY5nGx_HPj8130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231136.RAjXSuPbySNeZWo3zbJv5JjVfJXrx8rbUOBY5nGx_HPj8130_provenance.
• NP1231137.RAlvvTYqKR-JEbSuGbW3MBd4KDb0ehk9fjXw13n1ZZS7A130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231137.RAlvvTYqKR-JEbSuGbW3MBd4KDb0ehk9fjXw13n1ZZS7A130_provenance.
• NP1231142.RAuTYVPoftno0KmivvtYg6LGGCfoTZ0VoR13OLuIq6XiU130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231142.RAuTYVPoftno0KmivvtYg6LGGCfoTZ0VoR13OLuIq6XiU130_provenance.
• NP1231145.RAjOMCDXDAIxyrbHesgSdS2bnXup3KQ-QlXxO_MAUSV_Q130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231145.RAjOMCDXDAIxyrbHesgSdS2bnXup3KQ-QlXxO_MAUSV_Q130_provenance.
• NP1231146.RAnMfWYJsgt9-v8wxBA4uCDLMNqEPVPNAmlEtJIQFhd20130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231146.RAnMfWYJsgt9-v8wxBA4uCDLMNqEPVPNAmlEtJIQFhd20130_provenance.
• NP1231143.RAP9KLdVTBZD2lg3P5IEY_3FNrNn6hlGOOweRZhdRTCYs130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231143.RAP9KLdVTBZD2lg3P5IEY_3FNrNn6hlGOOweRZhdRTCYs130_provenance.
• NP1231130.RA-LXqp86tCDyjaykj6j8WMp7b7L0MVwQx3jhH0t-Hsew130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231130.RA-LXqp86tCDyjaykj6j8WMp7b7L0MVwQx3jhH0t-Hsew130_provenance.
• NP1231131.RA7rIYPz9mKz1I6LXycKz_1EA3C5pac2GfAdulTl7DUvE130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231131.RA7rIYPz9mKz1I6LXycKz_1EA3C5pac2GfAdulTl7DUvE130_provenance.
• NP1231139.RA34haK-Mley2IjhwFbV8OB259TyLDEQRtekC3cGp4p0Y130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231139.RA34haK-Mley2IjhwFbV8OB259TyLDEQRtekC3cGp4p0Y130_provenance.
• NP1231140.RA7DUfGlDiMve4rG1Qnb6aZxGAyW353fT9uNiMKIt6hno130_assertion description "[Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231140.RA7DUfGlDiMve4rG1Qnb6aZxGAyW353fT9uNiMKIt6hno130_provenance.